"A diagnosis of cancer can be a difficult, frightening and overwhelming time. That’s why the team of oncology specialists at the nationally-recognized Riverside Shore Cancer Center offers a very personalized approach to care that takes into account not only your medical needs, but also the concerns and emotional changes you’re experiencing along with the many questions you’re bound to have."

During the past decade, Riverside Shore Cancer Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverside Shore Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Riverside Shore Cancer Center" are "Colon Adenocarcinoma" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Diffuse Large B-Cell Lymphoma, Not Otherwise Specified" (1 trials), "Double-Expressor Lymphoma" (1 trials) and "EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified" (1 trials). Many other conditions were trialed in "Riverside Shore Cancer Center" in a lesser frequency.

Most popular intervention types in "Riverside Shore Cancer Center" are "Drug" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Carboplatin" (1 trials), "Comprehensive Geriatric Assessment" (1 trials), "Cyclophosphamide" (1 trials) and "Doxorubicin Hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Riverside Shore Cancer Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Riverside Shore Cancer Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Riverside Shore Cancer Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Riverside Shore Cancer Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".